Paper Details

  1. Home
  2. Paper Details

Hospital risk management of cutaneous herpes simplex virus infection.

Author: FengJ, YangH, ZhangJ, ZhuF

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.

Overview

This research examined the efficacy and safety of different formulations of valaciclovir for treating cutaneous herpes simplex infections (CHSIs). Valaciclovir is a commonly used antiviral medication for CHSIs, and the study explored potential differences in effectiveness based on dosage.
Paper Details　
Original Abstract of the Article :
The epidemiology of cutaneous herpes simplex infection (CHSI) has dramatically changed over the past several decades. Valaciclovir is one of a new generation of antiviral medications that has expanded treatment options for the most common cutaneous manifestations of herpes simplex virus. However, th...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1111/ced.12894

データ提供：米国国立医学図書館（NLM）

Managing Cutaneous Herpes Simplex Virus Infection: A Hospital Perspective

This study explores the evolving epidemiology of [cutaneous herpes simplex virus infection (CHSI)] and examines the role of [valaciclovir], a new generation antiviral medication, in its management. The authors discuss the changing landscape of CHSI and the expanding treatment options available for this common condition.

Navigating the Evolving Landscape of Herpes Simplex Virus Infection

The study highlights the significant shift in the epidemiology of CHSI, emphasizing the need for updated treatment strategies. Valaciclovir, with its diverse formulations and varying doses, offers promising new avenues for managing CHSI.

A Desert of Uncertainty: Exploring the Efficacy and Safety of Valaciclovir

The research underscores the need for further investigation into the efficacy and safety of valaciclovir formulations with different doses. Like a camel searching for a reliable water source in a vast desert, healthcare professionals need to carefully evaluate the effectiveness and safety of different treatment options, ensuring the optimal management of CHSI.

Dr. Camel's Conclusion

This research emphasizes the importance of staying abreast of the evolving landscape of infectious diseases, continuously adapting our knowledge and treatment strategies. Just as a camel adapts to the changing desert environment, healthcare professionals must remain vigilant in their pursuit of effective and safe treatments for CHSI.

Date :
  1. Date Completed 2018-02-05
  2. Date Revised 2018-12-02
Further Info :

Pubmed ID

27443451

DOI: Digital Object Identifier

10.1111/ced.12894

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.